| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 318,548 | 217,764 | 174,412 | 283,409 | | Cost of Revenue | 181,778 | 150,007 | 137,897 | 182,057 | | | Gross Profit | 136,770 | 67,757 | 36,515 | 101,352 | | | Operating Expenses | | Research Development | 71,199 | 67,491 | 70,434 | 68,781 | | Selling General and Administrative | 34,226 | 44,998 | 59,161 | 59,842 | | Non Recurring | 2,093 | 20,454 | 102,104 | 10,121 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 29,252 | (65,186) | (195,184) | (37,392) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (368) | 3,184 | 14,643 | (4,750) | | Earnings Before Interest And Taxes | 28,884 | (62,002) | (180,541) | (42,142) | | Interest Expense |
-
| 315 | 1,146 | 2,483 | | Income Before Tax | 28,884 | (62,317) | (181,687) | (44,625) | | Income Tax Expense | 12,087 | 26,173 | 16,672 | (20,453) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,797 | (88,490) | (198,359) | (24,172) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,797 | (88,490) | (198,359) | (24,172) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,797 | ($88,490) | ($198,359) | ($24,172) |
|
0.28% Nasdaq 0.00%
Income Statement
